Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.30
+2.63%
Mkt Cap $51.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $8.50M | $13.68M | +60.87% | -$0.13 | -$0.01 | +92.31% | — | — |
| Q4 2025 Nov 4, 2025 | — | $8.29M | — | — | -$0.06 | — | — | — |
| Q3 2025 Aug 5, 2025 | — | $10.84M | — | — | $0.02 | — | — | — |
| Q2 2025 May 6, 2025 | — | $11.71M | — | — | $0.16 | — | — | — |
| Q1 2025 Mar 4, 2025 | — | $10.44M | — | — | -$0.02 | — | — | — |
| Q4 2024 Nov 7, 2024 | — | $9.09M | — | — | -$0.02 | — | — | — |
| Q3 2024 Aug 6, 2024 | — | $9.85M | — | — | $0.01 | — | — | — |
| Q2 2024 May 7, 2024 | — | $8.50M | — | — | -$0.05 | — | — | — |
| Q1 2024 Mar 5, 2024 | — | $9.35M | — | — | -$0.11 | — | — | — |
| Q4 2023 Nov 7, 2023 | — | $10.09M | — | — | $0.02 | — | — | — |
| Q3 2023 Aug 8, 2023 | — | $10.89M | — | — | $0.16 | — | — | — |
| Q2 2023 May 9, 2023 | — | $9.22M | — | — | $0.11 | — | — | — |
| Q4 2022 Nov 8, 2022 | $8.07M | $11.41M | +41.37% | — | $0.10 | — | — | — |
| Q3 2022 Aug 9, 2022 | — | $10.30M | — | — | -$0.01 | — | — | — |
| Q2 2022 May 10, 2022 | $9.19M | $11.18M | +21.60% | — | $0.03 | — | — | — |
| Q1 2022 Mar 8, 2022 | $12.18M | $8.32M | -31.70% | -$0.01 | -$0.13 | -1200.00% | — | — |
| Q4 2021 Nov 9, 2021 | $9.19M | $8.07M | -12.16% | — | -$0.02 | — | — | — |
| Q3 2021 Aug 10, 2021 | $9.05M | $9.06M | +0.01% | -$0.07 | $0.08 | +216.16% | — | — |
| Q2 2021 May 11, 2021 | $8.50M | $10.54M | +23.97% | -$0.07 | $0.07 | +200.00% | — | — |
| Q1 2021 Mar 9, 2021 | $9.78M | $10.26M | +4.92% | $0.00 | $0.01 | +200.30% | — | — |